Your browser doesn't support javascript.
loading
Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.
Hernández-Gea, Virginia; Procopet, Bogdan; Giráldez, Álvaro; Amitrano, Lucio; Villanueva, Candid; Thabut, Dominique; Ibañez-Samaniego, Luis; Silva-Junior, Gilberto; Martinez, Javier; Genescà, Joan; Bureau, Christophe; Trebicka, Jonel; Llop, Elba; Laleman, Wim; Palazon, Jose Maria; Castellote, Jose; Rodrigues, Susana; Gluud, Lise L; Noronha Ferreira, Carlos; Barcelo, Rafael; Cañete, Nuria; Rodríguez, Manuel; Ferlitsch, Arnulf; Mundi, Jose Luis; Gronbaek, Henning; Hernández-Guerra, Manuel; Sassatelli, Romano; Dell'Era, Alessandra; Senzolo, Marco; Abraldes, Juan G; Romero-Gómez, Manuel; Zipprich, Alexander; Casas, Meritxell; Masnou, Helena; Primignani, Massimo; Krag, Aleksander; Nevens, Frederik; Calleja, Jose Luis; Jansen, Christian; Robic, Marie Angèle; Conejo, Irene; Catalina, Maria-Vega; Albillos, Agustin; Rudler, Marika; Alvarado, Edilmar; Guardascione, Maria Anna; Tantau, Marcel; Bosch, Jaime; Torres, Ferran; Garcia-Pagán, Juan Carlos.
Afiliación
  • Hernández-Gea V; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.
  • Procopet B; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
  • Giráldez Á; Regional Institute of Gastroenterology and Hepatology "Octavian Fodor", Hepatology Department and "Iuliu Hatieganu" University of Medicine and Pharmacy, 3rd Medical Clinic, Cluj-Napoca, Romania.
  • Amitrano L; Clinical Management Unit of Digestive Diseases, University Hospital Virgen del Rocio, Seville, Spain.
  • Villanueva C; Gastroenterology Unit, Ospedale A Cardarelli, Naples, Italy.
  • Thabut D; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
  • Ibañez-Samaniego L; Servei de Patologia Digestiva, Hospital de la Santa Creu i Sant Pau and CIBERehd, Barcelona, Spain.
  • Silva-Junior G; Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France.
  • Martinez J; Servicio de Medicina de Aparato Digestivo Gregorio Marañón, Hospital General Universitario Gregorio Marañón, liSGM, CIBERehd, Barcelona, Spain.
  • Genescà J; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi I i Sunyer, IMDIM, University of Barcelona, Barcelona, Spain.
  • Bureau C; Department of Gastroenterology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, CIBERehd, Madrid, Spain.
  • Trebicka J; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
  • Llop E; Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona and CIBERehd, Barcelona, Spain.
  • Laleman W; Department of Hepato-Gastroenterology, Purpan Hospital, CHU Toulouse, INSERM U858, University of Toulouse, France, Toulouse, France.
  • Palazon JM; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
  • Castellote J; European Foundation for the Study of Chronic Liver Failure (EF-Clif), Barcelona, Spain.
  • Rodrigues S; Institute for Bioengineering of Catalonia, Barcelona, Spain.
  • Gluud LL; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Noronha Ferreira C; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
  • Barcelo R; Liver Unit, Hospital U, Puerta de Hierro. Universidad Autònoma de Madrid, CIBERehd, Madrid, Spain.
  • Cañete N; Department of Liver and Biliopancreatic Disorders, University of Leuven, Leuven, Belgium.
  • Rodríguez M; Hospital General Universitario de Alicante, Alicante, Spain.
  • Ferlitsch A; Gastroenterology Department, Hepatology Unit, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
  • Mundi JL; Gastroenterology and Hepatology Department, Centro Hospitalar São João, Porto, Portugal.
  • Gronbaek H; Gastrounit, Medical Division, University Hospital of Hvidovre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hernández-Guerra M; Serviço de Gastrenterologia e Hepatologia, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, Portugal.
  • Sassatelli R; Medical Statistics Core Facility, Institut D'Investigacions Biomédiques August Pi i Sunyer, Hospital Clinic Barcelona, Barcelona, Spain.
  • Dell'Era A; Liver Section, Gastroenterology Department, Hospital del Mar, Universitat Autònoma de Barcelona, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Senzolo M; Department of Gastroenterology, Hospital Central de Asturias, Oviedo, Spain.
  • Abraldes JG; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Romero-Gómez M; Department of Gastroenterology, University Hospital San Cecilio, Granada, Spain.
  • Zipprich A; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Casas M; Gastroenterology Department, University Hospital of the Canary Islands, La Laguna, Tenerife, Spain.
  • Masnou H; Unit of Gastroenterology and Digestive Endoscopy, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy.
  • Primignani M; Gastroenterology Unit, ASST Fatebenefratelli Sacco, Department of Clinical and Biomedical Sciences, University of the Studies of Milan, Milan, Italy.
  • Krag A; Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua, Padua, Italy.
  • Nevens F; Cirrhosis Care Clinic, Division of Gastroenterology (Liver Unit), CEGIIR, University of Alberta, Edmonton, Canada.
  • Calleja JL; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
  • Jansen C; Unidad de Hepatología, Hospital Universitario de Valme, CIBERehd, Sevilla, Spain.
  • Robic MA; First Department of Internal Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
  • Conejo I; Hepatology Unit, Digestive Disease Department Hospital de Sabadell, Universitat Autónoma de Barcelona, Sabadell, Spain.
  • Catalina MV; Hospital Universitari Germans Trias i Pujol, Universitat Autònoma Barcelona, Badalona, Spain.
  • Albillos A; Division of Gastroenterology and Hepatology, IRCCS Ca' Granda Maggiore Hospital Foundation, University of Milan, Milan, Italy.
  • Rudler M; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
  • Alvarado E; Department of Liver and Biliopancreatic Disorders, University of Leuven, Leuven, Belgium.
  • Guardascione MA; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
  • Tantau M; Liver Unit, Hospital U, Puerta de Hierro. Universidad Autònoma de Madrid, CIBERehd, Madrid, Spain.
  • Bosch J; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
  • Torres F; Department of Hepato-Gastroenterology, Purpan Hospital, CHU Toulouse, INSERM U858, University of Toulouse, France, Toulouse, France.
  • Garcia-Pagán JC; Centro de Investigación Biomédica Red de enfermedades hepáticas y digestivas, Madrid, Spain.
Hepatology ; 69(1): 282-293, 2019 01.
Article en En | MEDLINE | ID: mdl-30014519
ABSTRACT
Patients admitted with acute variceal bleeding (AVB) and Child-Pugh C score (CP-C) or Child-Pugh B plus active bleeding at endoscopy (CP-B+AB) are at high risk for treatment failure, rebleeding, and mortality. A preemptive transjugular intrahepatic portosystemic shunt (p-TIPS) has been shown to improve survival in these patients, but its use in clinical practice has been challenged and not routinely incorporated. The present study aimed to further validate the role of preemptive TIPS in a large number of high-risk patients. This multicenter, international, observational study included 671 patients from 34 centers admitted for AVB and high risk of treatment failure. Patients were managed according to current guidelines, and use of drugs and endoscopic therapy (D+E) or p-TIPS was based on individual center policy. p-TIPS in the setting of AVB is associated with a lower mortality in CP-C patients compared with D+E (1 year mortality 22% vs. 47% in D+E group; P = 0.002). Mortality rate in CP-B+AB patients was low, and p-TIPS did not improve it. In CP-C and CP-B+AB patients, p-TIPS reduced treatment failure and rebleeding (1-year cumulative incidence function probability of remaining free of the composite endpoint 92% vs. 74% in the D+E group; P = 0.017) and development of de novo or worsening of previous ascites without increasing rates of hepatic encephalopathy.

Conclusion:

p-TIPS must be the treatment of choice in CP-C patients with AVB. Because of the strong benefit in preventing further bleeding and ascites, p-TIPS could be a good treatment strategy for CP-B+AB patients.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Várices Esofágicas y Gástricas / Derivación Portosistémica Intrahepática Transyugular / Prevención Secundaria / Hemorragia Gastrointestinal Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Várices Esofágicas y Gástricas / Derivación Portosistémica Intrahepática Transyugular / Prevención Secundaria / Hemorragia Gastrointestinal Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Año: 2019 Tipo del documento: Article País de afiliación: España